SEATTLE (AP) _ Neoleukin Therapeutics, Inc. (NLTX) on Wednesday reported a loss of $15 million in its first quarter.
The Seattle-based company said it had a loss of 27 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.
Neoleukin shares have decreased 19% since the beginning of the year. The stock has declined 14% in the last 12 months.
The Associated Press